Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023

Introduction and Objectives: Advanced liver fibrosis (ALF) is a predictor of adverse prognosis in chronic liver disease. In addition to etiological treatment, a new approach to stop or reverse residual fibrosis would be desirable. Our aim was to assess the efficacy and safety of a prolonged-release...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Linda E. Munoz-Espinosa, Aldo Torre, Laura Cisneros, Iaarah Montalvo-Gordon, René Malé-Velázquez, Scherezada Mejía, Juan Ramón Aguilar-Ramírez, Javier Lizardi-Cervera, María E. Icaza-Chávez, Frida Gasca-Díaz, Larissa Hernández-Hernández, Paula Cordero-Perez, Luis A. Chi-Cervera, Lilian Torres-Made, Fátima Rodríguez-Álvarez, Graciela Tapia, Jorge Luis Poo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-02-01
coleção:	Annals of Hepatology
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1665268124002667
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!